3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
5
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Melanoma
1
Locally Advanced Pancreatic Cancer
1
Gastric Adenocarcinoma
1
Gallbladder Cancer Unresectable
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Brain Neoplasms
1
Anal Cancer Metastatic
1
Interventions
Gemcitabine
17
Magnetic Resonance Spectroscopy
16
Specimen Handling
15
Cisplatin
12
pembrolizumab
11
enfortumab vedotin
7
Mitomycin
7
Cystoscopy
7
durvalumab
5
avelumab
5
Transurethral Resection of Bladder
5
Radiation
5
Fluorouracil
5
Carboplatin
5
Biopsy
5
Radiotherapy
4
Nivolumab
4
Cystectomy
4
tremelimumab
3
erdafitinib
3
dehydroftorafur
3
cabozantinib
3
atezolizumab
3
Platinum
3
Mitozytrex
3
Immunoglobulin G
3
Disulfides
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
sapanisertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
130-nm albumin-bound paclitaxel
×
30 days
×
Clear all
No trials found.